The World Health Organization said on Friday it had added its first monoclonal antibody tocilizumab to its so-called pre-qualification list, an official list of medicines used as a benchmark for procurement by developing countries.
The WHO recommended the drug, manufactured by Roche and typically used to treat arthritis, only for patients diagnosed with severe or critical COVID-19.
https://wtvbam.com/2022/02/11/who-adds-roches-arthritis-drug-tocilizumab-to-covid-19-medicines-list/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.